Samuel Hellman to Neoplasms
This is a "connection" page, showing publications Samuel Hellman has written about Neoplasms.
Connection Strength
1.125
-
Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial-Mesenchymal Transition. Clin Cancer Res. 2023 08 01; 29(15):2761-2766.
Score: 0.273
-
Oligometastases revisited. Nat Rev Clin Oncol. 2011 06; 8(6):378-82.
Score: 0.116
-
Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res. 2009 Jan 15; 69(2):383-92.
Score: 0.099
-
Unintended consequences. Nat Clin Pract Oncol. 2007 Aug; 4(8):439.
Score: 0.090
-
Evolving paradigms and perceptions of cancer. Nat Clin Pract Oncol. 2005 Dec; 2(12):618-24.
Score: 0.080
-
Debunking dogma and developing theses. Eur J Cancer. 2005 Mar; 41(4):489-90.
Score: 0.075
-
Darwin's clinical relevance. Cancer. 1997 Jun 15; 79(12):2275-81.
Score: 0.045
-
Roentgen Centennial Lecture: discovering the past, inventing the future. Int J Radiat Oncol Biol Phys. 1996 Apr 01; 35(1):15-20.
Score: 0.041
-
Radiation oncology and the new biology. Cancer J Sci Am. 1995 Sep-Oct; 1(3):174-9.
Score: 0.039
-
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
Score: 0.039
-
14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015 Feb 28; 6(6):3540-52.
Score: 0.038
-
Clinical cancer research: the past, present and the future. Nat Rev Clin Oncol. 2014 Nov; 11(11):663-9.
Score: 0.037
-
On first looking into Kutcher's "Contested Medicine": ethical tensions in clinical research. Perspect Biol Med. 2010; 53(2):304-14.
Score: 0.027
-
An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res. 2008 Aug 15; 14(16):5255-9.
Score: 0.024
-
Importance of local control in an era of systemic therapy. Nat Clin Pract Oncol. 2005 Feb; 2(2):60-1.
Score: 0.019
-
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity. Mol Cancer Ther. 2004 Sep; 3(9):1167-75.
Score: 0.018
-
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy. Lancet Oncol. 2002 Nov; 3(11):665-71.
Score: 0.016
-
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res. 2000 Dec 15; 60(24):6958-63.
Score: 0.014
-
The ethical lessons of managed care applied to clinical trials. Cancer Treat Res. 2000; 102:91-8.
Score: 0.013
-
Advances in radiation oncology. Lancet. 1997 May; 349 Suppl 2:SII1-3.
Score: 0.011
-
Radiation oncology. JAMA. 1996 Jun 19; 275(23):1852-3.
Score: 0.010